SCHEMBL24370231

SCHEMBL24370231

CNS(=O)(=O)c1ccc2ccc(CON3C(=O)c4ccccc4C3=O)cc2c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 1/20 0.51
▸ KMT2A Q03164 4/20 0.47
▸ MAPT P10636 3/20 0.47
▸ MEN1 O00255 3/20 0.47
▸ ALDH1A1 P00352 5/20 0.43
▸ VDR P11473 2/20 0.43
▸ KDM4E B2RXH2 2/20 0.43
▸ F2 P00734 1/20 0.43
▸ HTT P42858 1/20 0.39
▸ FGB P02675 1/20 0.39
▸ THRB P10828 1/20 0.39
▸ PABPC1 P11940 1/20 0.39
▸ PPARG P37231 1/20 0.39
▸ RECQL P46063 1/20 0.39
▸ NCOA2 Q15596 1/20 0.39
▸ NCOA1 Q15788 1/20 0.39
▸ NPSR1 Q6W5P4 1/20 0.39
▸ NCOA3 Q9Y6Q9 1/20 0.39
▸ POLB P06746 1/20 0.38
▸ NPY5R Q15761 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5558141 0.79 MEN1 (0.62) L3MBTL1KMT2AMAPTMEN1ALDH1A1
SCHEMBL2933951 0.74 KMT2A (0.63) L3MBTL1KMT2AMAPTMEN1ALDH1A1
SCHEMBL13141148 0.72 KMT2A (0.63) L3MBTL1KMT2AMAPTMEN1ALDH1A1
SCHEMBL3681833 0.70 L3MBTL1 (1.00) L3MBTL1KMT2AMEN1ALDH1A1F2
SCHEMBL29859681 0.70 L3MBTL1 (1.00) L3MBTL1KMT2AMEN1ALDH1A1F2
SCHEMBL26497891 0.70 MEN1 (0.65) L3MBTL1KMT2AMAPTMEN1ALDH1A1
SCHEMBL5528619 0.69 MEN1 (0.73) L3MBTL1KMT2AMAPTMEN1ALDH1A1
SCHEMBL22895135 0.69 MEN1 (0.59) L3MBTL1KMT2AMAPTMEN1ALDH1A1
SCHEMBL24168448 0.69 MEN1 (0.59) L3MBTL1KMT2AMAPTMEN1ALDH1A1
Bromide SCHEMBL28943112 0.69 MEN1 (0.63) L3MBTL1KMT2AMAPTMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220127228-A1 METHOD FOR PRODUCING DICHLORO ADDITION PRODUCT OF ALIPHATIC OLEFIN BY PHOTOCATALYSIS UNDER VISIBLE LIGHT SOOCHOW UNIVERSITY (CN) 2022-04-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220127228-A1 METHOD FOR PRODUCING DICHLORO ADDITION PRODUCT OF ALIPHATIC OLEFIN BY PHOTOCATALYSIS UNDER VISIBLE LIGHT AOC1, AOC2, AOC3 L3MBTL1 2390/4885KMT2A 1675/4885MAPT 1924/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback